My initial thoughts are that this split two-trial design allows Trial 2 to be open label.
With some google is my friend research, it also saves money since RAC doesn't pay for the patients in the Synthetic Control Arm ... smart!!!!
https://www.statnews.com/2019/02/05/synthetic-control-arms-clinical-trials/
Extract:
The benefits to the pharmaceutical industry are clear. By reducing or eliminating the need to enroll control participants, a synthetic control arm can increase efficiency, reduce delays, lower trial costs, and speed lifesaving therapies to market. Imagine a trial that needs to include have 500 participants in the treatment arm in order to demonstrate the effectiveness of a new therapy. Instead of having to recruit 1,000 patients — 500 for the active arm, 500 for the control arm — only 500 participants need to be recruited when a synthetic control arm is employed.
![]()
- Forums
- ASX - By Stock
- RAC
- Ann: Race 2022 AGM Presentations
Ann: Race 2022 AGM Presentations, page-23
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.53 |
Change
0.090(6.25%) |
Mkt cap ! $254.7M |
Open | High | Low | Value | Volume |
$1.46 | $1.55 | $1.46 | $146.7K | 97.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2252 | $1.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.55 | 850 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3195 | 1.530 |
2 | 753 | 1.525 |
3 | 1456 | 1.520 |
1 | 1050 | 1.515 |
1 | 1050 | 1.510 |
Price($) | Vol. | No. |
---|---|---|
1.550 | 500 | 1 |
1.560 | 2024 | 3 |
1.565 | 5296 | 1 |
1.570 | 2500 | 1 |
1.575 | 343 | 1 |
Last trade - 12.08pm 12/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |